IBD susceptibility loci contain genes in immune signaling pathways including tumor necrosis factor (TNF), interleukin (IL)-12, IL-23, and integrins, all important targets for interventional approaches in IBD [15]. The gene discussed is IL23A; the disease is inflammatory bowel disease.